| 1 |
Moradi Kashkooli F, Jakhmola A, Hornsby TK, Tavakkoli JJ, Kolios MC. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions. J Control Release 2023;355:552-78. [PMID: 36773959 DOI: 10.1016/j.jconrel.2023.02.009] [Reference Citation Analysis]
|
| 2 |
Nguyen TN, Chebbi I, Le Fèvre R, Guyot F, Alphandéry E. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer. Appl Microbiol Biotechnol 2023;107:1159-76. [PMID: 36633624 DOI: 10.1007/s00253-022-12247-9] [Reference Citation Analysis]
|
| 3 |
Ji J, Yang C, Shan Y, Sun M, Cui X, Xu L, Liang S, Li T, Fan Y, Luo D, Li Z. Research Trends of Piezoelectric Nanomaterials in Biomedical Engineering. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200088] [Reference Citation Analysis]
|
| 4 |
Li D, Zhuang P, Mei X. Flexible regulation of reactive oxygen species by sustainable cluster drugs. Materials Today Chemistry 2022;26:101093. [DOI: 10.1016/j.mtchem.2022.101093] [Reference Citation Analysis]
|
| 5 |
Yang Y, Huang J, Liu M, Qiu Y, Chen Q, Zhao T, Xiao Z, Yang Y, Jiang Y, Huang Q, Ai K. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy. Adv Sci (Weinh) 2023;10:e2204365. [PMID: 36437106 DOI: 10.1002/advs.202204365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Ayana G, Ryu J, Choe SW. Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy. Micromachines (Basel) 2022;13:1508. [PMID: 36144131 DOI: 10.3390/mi13091508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Shakerzadeh E, Tahmasebi E, Van Duong L, Tho Nguyen M. Boron Clusters in Biomedical Applications: A Theoretical Viewpoint. Characteristics and Applications of Boron [Working Title] 2022. [DOI: 10.5772/intechopen.106215] [Reference Citation Analysis]
|
| 8 |
Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
